Chimerix (NASDAQ: CMRX) reported Q4 EPS of ($0.52), $0.04 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $970 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.